PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€31.20
Target price
20.06.25
€49.47
Performance (%)
-2.56%
Price
24.07.24
€30.80
Summary
This prediction is currently active. With a performance of -2.56%, the BUY prediction for PTC Therapeutics Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 20.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -1.290% | -1.290% |
| iShares Core DAX® | -0.612% | 0.567% |
| iShares Nasdaq 100 | -3.018% | -3.205% |
| iShares Nikkei 225® | -2.647% | 0.330% |
| iShares S&P 500 | -1.932% | -1.126% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $53.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€48.82
21.05.25
21.05.25
-12.00%
24.07.24
24.07.24
